CG Oncology, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003, which is in phase 3 clinical trial for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 that is in phase 2 clinical trial to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy that is in phase 3 clinical trial for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008, which is in phase 2 clinical trial for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is based in Irvine, California.

CG Oncology, Inc. Common stock

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH). CG Onc...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

In a report released today, Alec Stranahan from Bank of America Securities reiterated a Buy rating on CG Oncology, Inc., with a price target of $88...

Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annexon Biosciences (ANNX) and CG Oncology, Inc. (CG...

Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)

Analysts see a few thematic ETFs that stand out this August for investors seeking long‑run growth in digital assets and healthcare. These include t...

3 Best ETFs With 50%+ Upside to Buy in August 2026, According to Analysts

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Phibro Animal Health (PAHC), Universal Health (UHS...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CGON	$75.03	0.00%	748.89K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CGON	$75.03	0%	748.89K
3
4
5
6

CGON

Get CG Oncology, Inc. Common stock Data in Excel

Get CG Oncology, Inc. Common stock Data in Excel